-The Times of India The Union health ministry is pushing to decriminalize the act of attempting suicide, which currently is an offence under Section 309 of the IPC with a punishment of up to one year in jail and a fine. The new Mental Health Care Bill 2012, that is expected to be tabled in the winter session, aims to introduce a provision saying "no complaint, investigation or prosecution shall be entertained...
More »SEARCH RESULT
India's first Japanese encephalitis vaccine launched
-PTI Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral DISEase. The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here. "The vaccine, which will also be exported, has good...
More »Government to assure, not insure, health--Vidya Krishnan and Anuja
-Live Mint NAC wants Rashtriya Swasthya Bima Yojna to be absorbed into new policy for universal health coverage The National Advisory Council (NAC), which sets the policy agenda for the Congress party led United Progressive Alliance (UPA) government, wants the Rashtriya Swasthya Bima Yojna (RSBY) insurance scheme to be absorbed into the new policy for universal health coverage (UHC), taking the latter closer to realization. This is part of the government’s bid to move...
More »Women and Girls at Heart of the Blue Revolution-Lakshmi Puri
-IPS News World Water Week recently concluded in Stockholm with a special emphasis on the linkages between water and food security. From the worst drought in 56 years in the United States Midwest, to the Karnataka’s drought in India, to the protracted drought in the Sahel region of West Africa, we have also seen how in our globalised world the nexus between lack of water and food security in one corner of...
More »Dengue still retains its deadly bite -R Prasad
-The Hindu Vaccine’s overall efficacy in a recent trial is ‘lower than expected’ The just concluded Phase IIb (proof-of-concept) dengue vaccine trial against all the four virus types (serotypes) that cause dengue has not only shown an unexpectedly low efficacy of 30.2 per cent but has also challenged many well-established hypotheses and ideas. The trial was conducted in about 4,000 children in the age group 4 and 11 in the dengue endemic district...
More »